Unaudited Standalone and Consolidated Financial Results with Limited Review Report for the quarter and half year ended on 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ARCL Organics reported strong results for Q2 and H1 FY26 (ended 30 September 2025). Standalone revenue from operations rose to ₹153.53 crore in H1 FY26 vs ₹116.39 crore in H1 FY25, a growth of about 32% year-on-year. Standalone profit after tax surged to ₹10.89 crore in H1 FY26 (₹7.08 crore in Q2 alone) from ₹4.62 crore in H1 FY25, more than doubling YoY. EBITDA margin also expanded materially, with profit before tax margin rising to around 9.6% in H1 FY26 from about 6.1% a year ago. The auditor (L.B. Jha & Co.) issued an unqualified limited review report on both standalone and consolidated results. Consolidated PAT for H1 FY26 stood at ₹11.21 crore.
Shareholders see a sharp turnaround with revenue growing over 30% and profits more than doubling, alongside margin expansion — clearly positive for the stock. However, cash flow from operations was very weak (just ₹29.88 lakh for H1 standalone vs ₹10.89 crore reported PAT), and cash balance fell to ₹14.99 lakh, signalling earnings quality and working capital warrant close monitoring.